Synergistic effects of nuclear transcription factor...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/12 (2006.01) A61K 31/44 (2006.01)

Patent

CA 2483340

The present invention provides methods of inhibiting metastasis of a tumor and methods of treating a tumor using a combination of an inhibitor of the activation of nuclear factor NF-.kappa.B and a cancer chemotherapeutic agent. In one embodiment of the present invention, combination of curcumin and paclitaxel (taxol) can be used to treat and inhibit metastasis of breast tumor.

la présente invention concerne des méthodes propres à inhiber les métastases d'une tumeur et à traiter une tumeur à l'aide d'une combinaison d'un inhibiteur du facteur d'activation du facteur nucléaire NF-?B et d'un agent chimiothérapeutique du cancer. Dans un mode de réalisation de la présente invention, on peut utiliser une combinaison de curcumine et de paclitaxel (taxol) pour traiter et inhiber les métastases de la tumeur du sein.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Synergistic effects of nuclear transcription factor... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Synergistic effects of nuclear transcription factor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synergistic effects of nuclear transcription factor... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1733495

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.